Paulina Stehlik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Paulina Stehlik has a total of 144 co-authors. Here are the top co-authors by number of shared publications:
- David Henry
Affiliations School of Population Health, Faculty of Medicine and Health, UNSW Sydney, Sydney, New South Wales, Australia, Institute for Evidence Based Healthcare, Bond University, Gold Coast, Queensland, Australia
10 shared publications - Paul Glasziou
Institute for Evidence-Based Healthcare, Bond University, Robina, Queensland, Australia
10 shared publications - Caitlin Brandenburg
Centre for Functioning and Health Research, Metro South Health, Brisbane, Australia
7 shared publications Caitlyn Withers
Gold Coast Hospital and Health Service Gold Coast QLD
4 shared publications- Christy Noble
Academy for Medical Education, Medical School The University of Queensland Brisbane Queensland Australia
4 shared publications Kylie Alcorn
Gold Coast University Hospital, Southport, Queensland, Australia
3 shared publications
Latest Publications
- 14 February 2026
- Published by Oxford University Press (OUP) in International Journal of Pharmacy Practice
- Vol. 34 (4) , 464-477
Pharmacy in Australia: are we research ready?
- 14 February 2026
- Published by Oxford University Press (OUP) in International Journal of Pharmacy Practice
- Vol. 34 (4) , 464-477
Pharmacy in Australia: are we research ready?
- 8 December 2025
- Published by Wiley in Medical Journal of Australia
- Vol. 223 (11) , 677
Mandatory research projects during medical specialist training in Australia and New Zealand
- 8 December 2025
- Published by Wiley in Medical Journal of Australia
- Vol. 223 (11) , 677
Mandatory research projects during medical specialist training in Australia and New Zealand
- Open Access
- 4 April 2025
- Published by Oxford University Press (OUP) in International Journal of Pharmacy Practice
- Vol. 33 (3) , 256-261
Community pharmacists’ referrals to General Practice with suspected need of antibiotics: an Australian cross-sectional pilot study
Background: Interventions to reduce antibiotic use focus on general practitioners (GPs) and patient behaviour, not pharmacists, who may inadvertently drive antibiotic expectations by referrals to GPs. No data are available on pharmacist referrals for suspected antibiotic-requiring infections. We conducted a feasibility pilot to provide data for robust sample size calculation and identify areas for further exploration. Method: Pharmacists and GPs were recruited independently using convenience sampling. They completed prospective data collection on 20 consecutive minor ailment encounters and consultations respectively. Pharmacists recorded patient gender, age, referral reason, and any comments. GPs recorded patient age, gender, reason for visit, and origin of patient referral including self-referral. All data were analysed descriptively. Generalized estimating equation multivariable logistic regression was used to investigate factors that may be associated with pharmacist referral rates. Results: We recruited 19 pharmacists representing 466 minor ailments encounters, and 19 GPs representing 394 consultations. Pharmacists referred 17% (77/466) of all minor ailments encounters for suspected antibiotic-requiring infections. Comments suggested reasons included upper-respiratory tract, ear nose and throat, and urinary tract infections. Most of suspected antibiotic-requiring infections referrals were to a GP (81%; 62/77). No GP consultations for infection (n = 88) were documented as being referred by a pharmacist; the majority were self-referred (77%; 68/88). Discussion: Our pilot indicated that exploration of pharmacist referral for antibiotics is feasible and warranted. Future studies should quantify referral rates, reasons for referral, and observed differences between pharmacist and GP results. Our results should be used for the basis of a robust sample size calculation.
- 4 April 2025
- Published by Oxford University Press (OUP) in International Journal of Pharmacy Practice
- Vol. 33 (3) , 256-261
Open AccessCommunity pharmacists’ referrals to General Practice with suspected need of antibiotics: an Australian cross-sectional pilot study
Background: Interventions to reduce antibiotic use focus on general practitioners (GPs) and patient behaviour, not pharmacists, who may inadvertently drive antibiotic expectations by referrals to GPs. No data are available on pharmacist referrals for suspected antibiotic-requiring infections. We conducted a feasibility pilot to provide data for robust sample size calculation and identify areas for further exploration. Method: Pharmacists and GPs were recruited independently using convenience sampling. They completed prospective data collection on 20 consecutive minor ailment encounters and consultations respectively. Pharmacists recorded patient gender, age, referral reason, and any comments. GPs recorded patient age, gender, reason for visit, and origin of patient referral including self-referral. All data were analysed descriptively. Generalized estimating equation multivariable logistic regression was used to investigate factors that may be associated with pharmacist referral rates. Results: We recruited 19 pharmacists representing 466 minor ailments encounters, and 19 GPs representing 394 consultations. Pharmacists referred 17% (77/466) of all minor ailments encounters for suspected antibiotic-requiring infections. Comments suggested reasons included upper-respiratory tract, ear nose and throat, and urinary tract infections. Most of suspected antibiotic-requiring infections referrals were to a GP (81%; 62/77). No GP consultations for infection (n = 88) were documented as being referred by a pharmacist; the majority were self-referred (77%; 68/88). Discussion: Our pilot indicated that exploration of pharmacist referral for antibiotics is feasible and warranted. Future studies should quantify referral rates, reasons for referral, and observed differences between pharmacist and GP results. Our results should be used for the basis of a robust sample size calculation.
- Open Access
- 25 February 2025
- Published by Wiley in Medical Journal of Australia
- Vol. 222 (5) , 231-239
Mandatory research projects during medical specialist training in Australia and New Zealand: a survey of trainees’ experiences and reports
Objective: To determine how many specialist trainees are required to conduct research projects, how they conduct these studies, and their views on the value of these activities; to assess the design and reporting quality of their research reports.Study design: Online, anonymous survey.Setting, participants: Current and recent trainees (past five years) at Australian and New Zealand specialist colleges, recruited through eleven colleges and snowballing; survey was available 31 March – 31 December 2021.Main outcome measures: Whether trainees were required to conduct research as part of specialty training; how they conducted their projects; the skills mix of the project team and access to relevant expertise and supervision; trainee views on mandatory research during specialty training; research engagement after training. Respondents were invited to submit project reports for reporting and methodological quality evaluation.Results: A total of 371 people commenced the survey; 361 respondents provided answers about mandatory research projects during specialist training, including 311 (86%) who had been required to complete projects. Seventy‐six of 177 people who had completed projects (43%) provided information about 92 projects and submitted 34 project reports for evaluation. Thirty‐eight projects (41%) investigated questions developed by the trainees alone; in 48 cases (52%) trainees had planned their projects with little outside input; of the 69 study protocols developed (75% of projects), 60 were developed by the trainees. The median proportion of time devoted to the research project exceeded 50% for trainees in ten of twelve colleges. Respondents typically worked in non‐collaborative teams, restricted to members of their own specialty, and additional expertise was limited to statisticians, allied health professionals, and nurses. Eighty‐seven of 174 participants who had completed projects (50%) felt that doing so was very or moderately important for their clinical careers; 36 of 67 respondents (54%) supported the requirement for scholarly projects during specialty training; 33 of 61 respondents (54%) had participated in research after completing training, and 44 (72%) had considered doing so. Twenty‐five of 34 available reports had been published; in 27 assessable reports, methods and results reporting was generally poor, and the risk of bias moderate to high in all but three. Participants criticised using their own time for projects and their potentially low quality results.Conclusion: For trainees who undertake specialty training, the time commitment and poor quality research associated with mandatory research projects were frequently concerns. Medical colleges should focus on research training tailored to individual career aspirations and training needs.
- 25 February 2025
- Published by Wiley in Medical Journal of Australia
- Vol. 222 (5) , 231-239
Open AccessMandatory research projects during medical specialist training in Australia and New Zealand: a survey of trainees’ experiences and reports
Objective: To determine how many specialist trainees are required to conduct research projects, how they conduct these studies, and their views on the value of these activities; to assess the design and reporting quality of their research reports.Study design: Online, anonymous survey.Setting, participants: Current and recent trainees (past five years) at Australian and New Zealand specialist colleges, recruited through eleven colleges and snowballing; survey was available 31 March – 31 December 2021.Main outcome measures: Whether trainees were required to conduct research as part of specialty training; how they conducted their projects; the skills mix of the project team and access to relevant expertise and supervision; trainee views on mandatory research during specialty training; research engagement after training. Respondents were invited to submit project reports for reporting and methodological quality evaluation.Results: A total of 371 people commenced the survey; 361 respondents provided answers about mandatory research projects during specialist training, including 311 (86%) who had been required to complete projects. Seventy‐six of 177 people who had completed projects (43%) provided information about 92 projects and submitted 34 project reports for evaluation. Thirty‐eight projects (41%) investigated questions developed by the trainees alone; in 48 cases (52%) trainees had planned their projects with little outside input; of the 69 study protocols developed (75% of projects), 60 were developed by the trainees. The median proportion of time devoted to the research project exceeded 50% for trainees in ten of twelve colleges. Respondents typically worked in non‐collaborative teams, restricted to members of their own specialty, and additional expertise was limited to statisticians, allied health professionals, and nurses. Eighty‐seven of 174 participants who had completed projects (50%) felt that doing so was very or moderately important for their clinical careers; 36 of 67 respondents (54%) supported the requirement for scholarly projects during specialty training; 33 of 61 respondents (54%) had participated in research after completing training, and 44 (72%) had considered doing so. Twenty‐five of 34 available reports had been published; in 27 assessable reports, methods and results reporting was generally poor, and the risk of bias moderate to high in all but three. Participants criticised using their own time for projects and their potentially low quality results.Conclusion: For trainees who undertake specialty training, the time commitment and poor quality research associated with mandatory research projects were frequently concerns. Medical colleges should focus on research training tailored to individual career aspirations and training needs.
- Open Access
Community pharmacists’ referrals to General Practice with suspected need of antibiotics: a national prospective pilot
Background Interventions to minimise community antibiotic use have focused on the GP and patient behaviour rather than the community pharmacist. Patient expectations are a known driver for antibiotic prescribing, and pharmacists may be inveterately contributing to these expectations by referring patients for GPs for suspected antibiotic-requiring infections (S-ARI). We sought to quantify these referral rates. Method Pharmacists and GPs were recruited independently using convenience sampling and completed prospective data collection on 20 minor ailment encounters and consecutive consultations respectively. Pharmacists recorded patient gender, age, referral reason and comments (if any). GPs recorded patient age, gender, reason for visit, and origin of patient referral including self-referral. All data were analysed descriptively. Generalised estimating equations, multivariable logistic regression was used to investigate factors that may be associated with pharmacist referral rates. Results Nineteen pharmacists representing 466 minor ailments encounters, and 19 GPs representing 394 consultations were recruited. Pharmacists referred 16.5% (77/466) of all minor ailments encounters for S-ARI. Comments suggested that reasons included upper-respiratory tract, ear nose and throat, and urinary tract infections. Most of S-ARI referrals were to a GP (62/466). None of the 88 consultations for infection in GP data were documented as being referred by a pharmacist; majority were self-referred (77.3%; 68/88). Discussion Pharmacists referred 1 in 8 minor ailments encounters to the GP for S-ARI, with some indication they were for conditions that do not require antibiotics. Most GP consultations for infection were documented as self-referrals. Both provide potential points of intervention to minimise antibiotic use.
Open AccessCommunity pharmacists’ referrals to General Practice with suspected need of antibiotics: a national prospective pilot
Background Interventions to minimise community antibiotic use have focused on the GP and patient behaviour rather than the community pharmacist. Patient expectations are a known driver for antibiotic prescribing, and pharmacists may be inveterately contributing to these expectations by referring patients for GPs for suspected antibiotic-requiring infections (S-ARI). We sought to quantify these referral rates. Method Pharmacists and GPs were recruited independently using convenience sampling and completed prospective data collection on 20 minor ailment encounters and consecutive consultations respectively. Pharmacists recorded patient gender, age, referral reason and comments (if any). GPs recorded patient age, gender, reason for visit, and origin of patient referral including self-referral. All data were analysed descriptively. Generalised estimating equations, multivariable logistic regression was used to investigate factors that may be associated with pharmacist referral rates. Results Nineteen pharmacists representing 466 minor ailments encounters, and 19 GPs representing 394 consultations were recruited. Pharmacists referred 16.5% (77/466) of all minor ailments encounters for S-ARI. Comments suggested that reasons included upper-respiratory tract, ear nose and throat, and urinary tract infections. Most of S-ARI referrals were to a GP (62/466). None of the 88 consultations for infection in GP data were documented as being referred by a pharmacist; majority were self-referred (77.3%; 68/88). Discussion Pharmacists referred 1 in 8 minor ailments encounters to the GP for S-ARI, with some indication they were for conditions that do not require antibiotics. Most GP consultations for infection were documented as self-referrals. Both provide potential points of intervention to minimise antibiotic use.
- Open Access
Evol ution of the data and methods in real-world COVID-19 vaccine effectiveness studies on mortality: a sc oping r eview protocol
Background Early evidence on COVID-19 vaccine efficacy came from randomised trials. Many important questions subsequently about vaccine effectiveness (VE) have been addressed using real-world studies (RWS) and have informed most vaccination policies globally. As the questions about VE have evolved during the pandemic so have data, study design, and analytical choices. This scoping review aims to characterise this evolution and provide insights for future pandemic planning—specifically, what kinds of questions are asked at different stages of a pandemic, and what data infrastructure and methods are used? Methods and analysis We will identify relevant studies in the Johns Hopkins Bloomberg School of Public Health VIEW-hub database, which curates both published and preprint VE RWS identified from PubMed, Embase, Scopus, Web of Science, the WHO COVID Database, MMWR, Eurosurveillance, medRxiv, bioRxiv, SSRN, Europe PMC, Research Square, Knowledge Hub, and Google. We will include RWS of COVID-19 VE that reported COVID-19-specific or all-cause mortality (coded as ‘death’ in the ‘effectiveness studies’ data set). Information on study characteristics; study context; data sources; design and analytic methods that address confounding will be extracted by single reviewer and checked for accuracy and discussed in a small group setting by methodological and analytic experts. A timeline mapping approach will be used to capture the evolution of this body of literature. By describing the evolution of RWS of VE through the COVID-19 pandemic, we will help identify options for VE studies and inform policy makers on the minimal data and analytic infrastructure needed to support rapid RWS of VE in future pandemics and of healthcare strategies more broadly. Ethics and dissemination As data is in the public domain, ethical approval is not required. Findings of this study will be disseminated through peer-reviewed publications, conference presentations, and working-papers to policy makers. Registration https://doi.org/10.17605/OSF.IO/ZHDKR
Open AccessEvol ution of the data and methods in real-world COVID-19 vaccine effectiveness studies on mortality: a sc oping r eview protocol
Background Early evidence on COVID-19 vaccine efficacy came from randomised trials. Many important questions subsequently about vaccine effectiveness (VE) have been addressed using real-world studies (RWS) and have informed most vaccination policies globally. As the questions about VE have evolved during the pandemic so have data, study design, and analytical choices. This scoping review aims to characterise this evolution and provide insights for future pandemic planning—specifically, what kinds of questions are asked at different stages of a pandemic, and what data infrastructure and methods are used? Methods and analysis We will identify relevant studies in the Johns Hopkins Bloomberg School of Public Health VIEW-hub database, which curates both published and preprint VE RWS identified from PubMed, Embase, Scopus, Web of Science, the WHO COVID Database, MMWR, Eurosurveillance, medRxiv, bioRxiv, SSRN, Europe PMC, Research Square, Knowledge Hub, and Google. We will include RWS of COVID-19 VE that reported COVID-19-specific or all-cause mortality (coded as ‘death’ in the ‘effectiveness studies’ data set). Information on study characteristics; study context; data sources; design and analytic methods that address confounding will be extracted by single reviewer and checked for accuracy and discussed in a small group setting by methodological and analytic experts. A timeline mapping approach will be used to capture the evolution of this body of literature. By describing the evolution of RWS of VE through the COVID-19 pandemic, we will help identify options for VE studies and inform policy makers on the minimal data and analytic infrastructure needed to support rapid RWS of VE in future pandemics and of healthcare strategies more broadly. Ethics and dissemination As data is in the public domain, ethical approval is not required. Findings of this study will be disseminated through peer-reviewed publications, conference presentations, and working-papers to policy makers. Registration https://doi.org/10.17605/OSF.IO/ZHDKR
- Open Access
A cross sectional survey of Australian and New Zealand specialist trainees’ research experiences and outputs
Objective To explore medical trainees’ experiences and views concerning college-mandated research projects. Setting Online survey (Apr-Dec 2021) of current and recent past trainees of Australian and New Zealand colleges recruited through 11 principal colleges and snowballing. Participants Current trainee or completed training in the past 5 years. Main outcome measures We asked participants: whether they were required to conduct research as part of their college training, how they conducted their research, and their research activity after training. Respondents were invited to submit project reports for reporting and methodological quality evaluation. Data were analysed descriptively. Results Of the 372 respondents, 313 (86%) were required to complete one or more projects. Of the 177 who had completed their project (representing 267 projects), 76 provided information on 92 studies, with 34 reports submitted for evaluation. Most respondents developed their own research questions, study design and protocol, and conducted research in their own time, with 56% (38/68) stating they had the skills to complete their project. Most project teams consisted of their own medical specialty followed by statisticians, but seldom others. 44% (30/68) were satisfied with their research experience, and 53% (36/67) supported mandatory projects. Half (87/174) felt research was important for career development, 72% (44/61) considered initiating research post-training, and 54% (33/61) participated in it. Commonly expressed themes were time-burden of conducting projects, production of research waste, and the importance of research for skills development. Of the 34 submitted reports, 75% were published and 82% had a clear research question. Only three had a low risk of bias. Conclusion Majority of respondents conducted projects, but few shared details or reports. Despite valuing their research experiences and seeing clinical relevance, time conflicts and research waste were common concerns. Colleges should focus on enhanced research methods training and creating trainee research collaboratives. Protocol registration https://doi.org/10.17605/OSF.IO/BNGZK Summary box Majority of medical specialty trainees are required to conduct a research project to develop their research skills. We found the learning experiences are inconsistent, and the quality of research produced even more so. A new approach is required that is tailored to the research skills required by most practicing clinicians, namely being expert in applying research to practice and in participating in collaborative research. Those wishing to become leaders in research should be supported to do so via a specialised well-supported pathway.
Open AccessA cross sectional survey of Australian and New Zealand specialist trainees’ research experiences and outputs
Objective To explore medical trainees’ experiences and views concerning college-mandated research projects. Setting Online survey (Apr-Dec 2021) of current and recent past trainees of Australian and New Zealand colleges recruited through 11 principal colleges and snowballing. Participants Current trainee or completed training in the past 5 years. Main outcome measures We asked participants: whether they were required to conduct research as part of their college training, how they conducted their research, and their research activity after training. Respondents were invited to submit project reports for reporting and methodological quality evaluation. Data were analysed descriptively. Results Of the 372 respondents, 313 (86%) were required to complete one or more projects. Of the 177 who had completed their project (representing 267 projects), 76 provided information on 92 studies, with 34 reports submitted for evaluation. Most respondents developed their own research questions, study design and protocol, and conducted research in their own time, with 56% (38/68) stating they had the skills to complete their project. Most project teams consisted of their own medical specialty followed by statisticians, but seldom others. 44% (30/68) were satisfied with their research experience, and 53% (36/67) supported mandatory projects. Half (87/174) felt research was important for career development, 72% (44/61) considered initiating research post-training, and 54% (33/61) participated in it. Commonly expressed themes were time-burden of conducting projects, production of research waste, and the importance of research for skills development. Of the 34 submitted reports, 75% were published and 82% had a clear research question. Only three had a low risk of bias. Conclusion Majority of respondents conducted projects, but few shared details or reports. Despite valuing their research experiences and seeing clinical relevance, time conflicts and research waste were common concerns. Colleges should focus on enhanced research methods training and creating trainee research collaboratives. Protocol registration https://doi.org/10.17605/OSF.IO/BNGZK Summary box Majority of medical specialty trainees are required to conduct a research project to develop their research skills. We found the learning experiences are inconsistent, and the quality of research produced even more so. A new approach is required that is tailored to the research skills required by most practicing clinicians, namely being expert in applying research to practice and in participating in collaborative research. Those wishing to become leaders in research should be supported to do so via a specialised well-supported pathway.
- Top Cited PapersOpen Access
- 28 February 2023
- Published by BMJ in BMJ Medicine
- Vol. 2 (1) , e000385
Effect of covid-19 vaccination on long covid: systematic review
Objective To determine the effect of covid-19 vaccination, given before and after acute infection with the SARS-CoV-2 virus, or after a diagnosis of long covid, on the rates and symptoms of long covid. Design Systematic review. Data sources PubMed, Embase, and Cochrane covid-19 trials, and Europe PubMed Central (Europe PMC) for preprints, from 1 January 2020 to 3 August 2022. Eligibility criteria for selecting studies Trials, cohort studies, and case-control studies reporting on patients with long covid and symptoms of long covid, with vaccination before and after infection with the SARS-CoV-2 virus, or after a diagnosis of long covid. Risk of bias was assessed with the ROBINS-I tool. Results 1645 articles were screened but no randomised controlled trials were found. 16 observational studies from five countries (USA, UK, France, Italy, and the Netherlands) were identified that reported on 614 392 patients. The most common symptoms of long covid that were studied were fatigue, cough, loss of sense of smell, shortness of breath, loss of taste, headache, muscle ache, difficulty sleeping, difficulty concentrating, worry or anxiety, and memory loss or confusion. 12 studies reported data on vaccination before infection with the SARS-CoV-2 virus, and 10 showed a significant reduction in the incidence of long covid: the odds ratio of developing long covid with one dose of vaccine ranged from 0.22 to 1.03; with two doses, odds ratios were 0.25-1; with three doses, 0.16; and with any dose, 0.48-1.01. Five studies reported on vaccination after infection, with odds ratios of 0.38-0.91. The high heterogeneity between studies precluded any meaningful meta-analysis. The studies failed to adjust for potential confounders, such as other protective behaviours and missing data, thus increasing the risk of bias and decreasing the certainty of evidence to low. Conclusions Current studies suggest that covid-19 vaccines might have protective and therapeutic effects on long covid. More robust comparative observational studies and trials are needed, however, to clearly determine the effectiveness of vaccines in preventing and treating long covid. Protocol registration Open Science Framework https://osf.io/e8jdy.
- 28 February 2023
- Published by BMJ in BMJ Medicine
- Vol. 2 (1) , e000385
Top Cited PapersOpen AccessEffect of covid-19 vaccination on long covid: systematic review
Objective To determine the effect of covid-19 vaccination, given before and after acute infection with the SARS-CoV-2 virus, or after a diagnosis of long covid, on the rates and symptoms of long covid. Design Systematic review. Data sources PubMed, Embase, and Cochrane covid-19 trials, and Europe PubMed Central (Europe PMC) for preprints, from 1 January 2020 to 3 August 2022. Eligibility criteria for selecting studies Trials, cohort studies, and case-control studies reporting on patients with long covid and symptoms of long covid, with vaccination before and after infection with the SARS-CoV-2 virus, or after a diagnosis of long covid. Risk of bias was assessed with the ROBINS-I tool. Results 1645 articles were screened but no randomised controlled trials were found. 16 observational studies from five countries (USA, UK, France, Italy, and the Netherlands) were identified that reported on 614 392 patients. The most common symptoms of long covid that were studied were fatigue, cough, loss of sense of smell, shortness of breath, loss of taste, headache, muscle ache, difficulty sleeping, difficulty concentrating, worry or anxiety, and memory loss or confusion. 12 studies reported data on vaccination before infection with the SARS-CoV-2 virus, and 10 showed a significant reduction in the incidence of long covid: the odds ratio of developing long covid with one dose of vaccine ranged from 0.22 to 1.03; with two doses, odds ratios were 0.25-1; with three doses, 0.16; and with any dose, 0.48-1.01. Five studies reported on vaccination after infection, with odds ratios of 0.38-0.91. The high heterogeneity between studies precluded any meaningful meta-analysis. The studies failed to adjust for potential confounders, such as other protective behaviours and missing data, thus increasing the risk of bias and decreasing the certainty of evidence to low. Conclusions Current studies suggest that covid-19 vaccines might have protective and therapeutic effects on long covid. More robust comparative observational studies and trials are needed, however, to clearly determine the effectiveness of vaccines in preventing and treating long covid. Protocol registration Open Science Framework https://osf.io/e8jdy.
- Top Cited PapersOpen Access
- 7 July 2022
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 20 (7) , e3001680
Recommendations for empowering early career researchers to improve research culture and practice
Early career researchers (ECRs) are important stakeholders leading efforts to catalyze systemic change in research culture and practice. Here, we summarize the outputs from a virtual unconventional conference (unconference), which brought together 54 invited experts from 20 countries with extensive experience in ECR initiatives designed to improve the culture and practice of science. Together, we drafted 2 sets of recommendations for (1) ECRs directly involved in initiatives or activities to change research culture and practice; and (2) stakeholders who wish to support ECRs in these efforts. Importantly, these points apply to ECRs working to promote change on a systemic level, not only those improving aspects of their own work. In both sets of recommendations, we underline the importance of incentivizing and providing time and resources for systems-level science improvement activities, including ECRs in organizational decision-making processes, and working to dismantle structural barriers to participation for marginalized groups. We further highlight obstacles that ECRs face when working to promote reform, as well as proposed solutions and examples of current best practices. The abstract and recommendations for stakeholders are available in Dutch, German, Greek (abstract only), Italian, Japanese, Polish, Portuguese, Spanish, and Serbian.
- 7 July 2022
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 20 (7) , e3001680
Top Cited PapersOpen AccessRecommendations for empowering early career researchers to improve research culture and practice
Early career researchers (ECRs) are important stakeholders leading efforts to catalyze systemic change in research culture and practice. Here, we summarize the outputs from a virtual unconventional conference (unconference), which brought together 54 invited experts from 20 countries with extensive experience in ECR initiatives designed to improve the culture and practice of science. Together, we drafted 2 sets of recommendations for (1) ECRs directly involved in initiatives or activities to change research culture and practice; and (2) stakeholders who wish to support ECRs in these efforts. Importantly, these points apply to ECRs working to promote change on a systemic level, not only those improving aspects of their own work. In both sets of recommendations, we underline the importance of incentivizing and providing time and resources for systems-level science improvement activities, including ECRs in organizational decision-making processes, and working to dismantle structural barriers to participation for marginalized groups. We further highlight obstacles that ECRs face when working to promote reform, as well as proposed solutions and examples of current best practices. The abstract and recommendations for stakeholders are available in Dutch, German, Greek (abstract only), Italian, Japanese, Polish, Portuguese, Spanish, and Serbian.
- Open Access
Impact of COVID-19 vaccination on long COVID: a systematic review and meta-analysis
Background: The impact of COVID-19 vaccination on preventing or treating long COVID is unclear. We aim to assess the impact of COVID vaccinations administered (i) before and (ii) after acute COVID-19, including vaccination after long COVID diagnosis, on the rates or symptoms of long COVID. Methods: We searched PubMed, Embase, Cochrane COVID-19 trials, and Europe PMC for preprints from 1 Jan 2020 to 16 Feb 2022. We included trials, cohort, and case control studies reporting on long COVID cases and symptoms with vaccine administration both before and after COVID-19 diagnosis as well as after long COVID diagnosis. Risk of bias was assessed using ROBINS-I. Results: We screened 356 articles and found no trials, but 6 observational studies from 3 countries (USA, UK, France) that reported on 442,601 patients. The most common long COVID symptoms studied include fatigue, cough, loss of smell, shortness of breath, loss of taste, headache, muscle ache, trouble sleeping, difficulty concentrating, worry or anxiety, and memory loss or confusion. Four studies reported data on vaccination before SARS-CoV-2 infection, of which three showed statistically significant reduction in long COVID: the odds ratio of developing long COVID with one dose of vaccine ranged between OR 0.22 to 1.03; with two doses OR 0.51 to 1; and with any dose OR 0.85 to 1.01. Three studies reported on post-infection vaccination with odds ratios between 0.38 to 0.91. The high heterogeneity between studies precluded any meaningful meta-analysis. Studies failed to adjust for potential confounders such as other protective behaviours, and missing data, thus increasing the risk of bias, and decreasing the certainty of evidence to low. Discussion: Current studies suggest that COVID-19 vaccinations may have protective and therapeutic effects on long COVID. However, more robust comparative observational studies and trials are urgently needed to clearly determine effectiveness of vaccines in prevention and treatment of long COVID.
Open AccessImpact of COVID-19 vaccination on long COVID: a systematic review and meta-analysis
Background: The impact of COVID-19 vaccination on preventing or treating long COVID is unclear. We aim to assess the impact of COVID vaccinations administered (i) before and (ii) after acute COVID-19, including vaccination after long COVID diagnosis, on the rates or symptoms of long COVID. Methods: We searched PubMed, Embase, Cochrane COVID-19 trials, and Europe PMC for preprints from 1 Jan 2020 to 16 Feb 2022. We included trials, cohort, and case control studies reporting on long COVID cases and symptoms with vaccine administration both before and after COVID-19 diagnosis as well as after long COVID diagnosis. Risk of bias was assessed using ROBINS-I. Results: We screened 356 articles and found no trials, but 6 observational studies from 3 countries (USA, UK, France) that reported on 442,601 patients. The most common long COVID symptoms studied include fatigue, cough, loss of smell, shortness of breath, loss of taste, headache, muscle ache, trouble sleeping, difficulty concentrating, worry or anxiety, and memory loss or confusion. Four studies reported data on vaccination before SARS-CoV-2 infection, of which three showed statistically significant reduction in long COVID: the odds ratio of developing long COVID with one dose of vaccine ranged between OR 0.22 to 1.03; with two doses OR 0.51 to 1; and with any dose OR 0.85 to 1.01. Three studies reported on post-infection vaccination with odds ratios between 0.38 to 0.91. The high heterogeneity between studies precluded any meaningful meta-analysis. Studies failed to adjust for potential confounders such as other protective behaviours, and missing data, thus increasing the risk of bias, and decreasing the certainty of evidence to low. Discussion: Current studies suggest that COVID-19 vaccinations may have protective and therapeutic effects on long COVID. However, more robust comparative observational studies and trials are urgently needed to clearly determine effectiveness of vaccines in prevention and treatment of long COVID.